BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24330570)

  • 1. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
    Uth J; Schmidt JF; Christensen JF; Hornstrup T; Andersen LJ; Hansen PR; Christensen KB; Andersen LL; Helge EW; Brasso K; Rørth M; Krustrup P; Midtgaard J
    BMC Cancer; 2013 Dec; 13():595. PubMed ID: 24330570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
    Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of community-based football compared to usual care in men with prostate cancer: Protocol for a randomised, controlled, parallel group, multicenter superiority trial (The FC Prostate Community Trial).
    Bjerre E; Bruun DM; Tolver A; Brasso K; Krustrup P; Johansen C; Christensen R; Rørth M; Midtgaard J
    BMC Cancer; 2016 Oct; 16(1):767. PubMed ID: 27716218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy.
    Uth J; Hornstrup T; Schmidt JF; Christensen JF; Frandsen C; Christensen KB; Helge EW; Brasso K; Rørth M; Midtgaard J; Krustrup P
    Scand J Med Sci Sports; 2014 Aug; 24 Suppl 1():105-12. PubMed ID: 24944134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial.
    Bjerre ED; Brasso K; Jørgensen AB; Petersen TH; Eriksen AR; Tolver A; Christensen JF; Poulsen MH; Madsen SS; Østergren PB; Borre M; Krustrup P; Johansen C; Rørth M; Midtgaard J
    Sports Med; 2019 Jan; 49(1):145-158. PubMed ID: 30506427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
    Trials; 2014 Sep; 15():354. PubMed ID: 25199619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Helge EW; Schmidt JF; Brasso K; Helge JW; Jakobsen MD; Andersen LL; Rørth M; Midtgaard J; Krustrup P
    Eur J Appl Physiol; 2016 Mar; 116(3):471-80. PubMed ID: 26620651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
    Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
    BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
    BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
    Winters-Stone KM; Li F; Horak F; Dieckmann N; Hung A; Amling C; Beer TM
    Trials; 2021 Nov; 22(1):775. PubMed ID: 34742325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SMH; Santa Mina D; Ritvo P; Tomlinson G; Sabiston C; Krahn M; Durbano S; Matthew A; Warde P; O'Neill M; Timilshina N; Segal R; Culos-Reed N
    BMC Cancer; 2019 Jan; 19(1):2. PubMed ID: 30606137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
    Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
    Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study.
    Braga-Basaria M; Travison TG; Taplin ME; Lin A; Dufour AB; Habtemariam D; Nguyen PL; Kibel AS; Ravi P; Bearup R; Kackley H; Kafel H; Reid K; Storer T; Simonson DC; McDonnell M; Basaria S
    PLoS One; 2023; 18(2):e0281508. PubMed ID: 36763576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.